Chart: Biotech Stocks - SG&A Margin (MRQ)

Selling, General and Administrative Expenses (most recently reported quarter) as a percentage of total revenue in the Biotech sector ranged from 844.3% (ALXN) down to 7.0% (IMCL), with a median value of 42.3%.

* View More Biotech Sector Charts *
Data in table version -- click on a ticker for opinion and analysis of the company:

			Total	SG&A	SG&A
		Quarter	Revenue	Expense	Margin
Ticker	Company	Ending	($mm)	($mm)	(%)
AFFX	Affymetrix Inc.	12/31/05	$86.39	$30.30
35.1%
ALXN	Alexion Pharmaceuticals Inc.	10/31/05	$0.77	$6.48
844.3%
AMGN	Amgen Inc.	12/31/05	$3217.00	$911.00
28.3%
AMLN	Amylin Pharmaceuticals Inc.	12/31/05	$82.35	$57.07
69.3%
BIIB	Biogen Idec Inc.	12/31/05	$611.18	$162.02
26.5%
BMRN	BioMarin Pharmaceutical Inc.	12/31/05	$13.81	$11.08
80.2%
BSTE	Biosite Incorporated	12/31/05	$79.33	$19.83
25.0%
CELG	Celgene Corporation	12/31/05	$181.84	$58.08
31.9%
DNA	Genentech Inc.	03/31/06	$1986.00	$474.00
23.9%
ELN	Elan Corp. plc	12/31/05	$134.30	$90.00
67.0%
GILD	Gilead Sciences Inc.	03/31/06	$692.88	$149.71
21.6%
GPRO	Gen-Probe Inc.	12/31/05	$86.26	$18.09
21.0%
IMCL	Imclone Systems Inc.	12/31/05	$245.13	$17.13
7.0%
INCY	Incyte Corp.	12/31/05	$6.47	$3.41
52.8%
ISTA	ISTA Pharmaceuticals Inc.	12/31/05	$3.68	$8.66
235.2%
KOSP	KOS Pharmaceuticals Inc.	12/31/05	$213.92	$100.99
47.2%
MEDI	MedImmune Inc.	03/31/06	$498.00	$217.90
43.8%
NABI	Nabi Biopharmaceuticals	12/31/05	$27.55	$17.19
62.4%
NBIX	Neurocrine Biosciences Inc.	12/31/05	$19.48	$13.94
71.6%
ONXX	Onyx Pharmaceuticals Inc.	12/31/05	N/A	$17.76
N/A
PGNX	Progenics Pharmaceuticals Inc.	12/31/05	$2.05	$4.18
204.1%
PHRM	Pharmion Corp.	12/31/05	$56.59	$23.14
40.9%
TELK	Telik Inc.	12/31/05	N/A	$2.74
N/A
VRTX	Vertex Pharmaceuticals Inc.	12/31/05	$39.09	$12.81
32.8%

Data: Capital IQ

Related:

1. Most recent opinion and analysis of Biotech stocks
2. Full transcripts of recent conference calls in the Biotech sector
3. Add the Biotech Stock Blog to your My Yahoo! page

Aside: Did you know that Seeking Alpha now publishes a daily recap of Jim Cramer's Mad Money stock picks?